With diabetes growing at epidemic rates, it stands to reason that every Tom, Dick and Harry are getting in on the action. Every day there’s a new drug, product, service, or technology that promises to be the next big thing in the wacky world of diabetes. Some of them are great, some of them are DOA, and a few of them might even be promising. At the Diabetic Investor, we take a look at all of it – the good, the bad and the ugly – and give you our unvarnished – and unbiased – opinion. We dive deep into the business of diabetes and provide our subscribers with inside information that gives them greater insight into the industry. What they do with that information is up to them. Diabetes Investor is the premier subscription-based content publisher that provides real time analysis of the business of diabetes – from pharma to med tech to devices and everything in between. If you’re seriously interested in gaining insights into the companies, products and technology that are playing in this space (or trying to get in), check out the different subscription packages at www.diabeticinvestor.com.